Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
| Actual shortage: | 234 (8%) | |
| Anticipated shortage: | 20 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LOPERAMIDE | 2MG | TABLET | Actual shortage | 2017-03-10 | 2017-10-05 | 372 |
| APO-LEVOFLOXACIN | 500MG | TABLET | Resolved | 2017-03-10 | 2017-03-16 | 369 |
| APO-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2017-03-10 | 2017-03-16 | 366 |
| APO-LATANOPROST | 50MCG | SOLUTION | Resolved | 2017-03-10 | 2020-02-13 | 363 |
| APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-10 | 2017-04-10 | 354 |
| APO-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-03-10 | 2017-04-24 | 351 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Resolved | 2017-03-10 | 2017-04-24 | 345 |
| APO-IRBESARTAN | 75MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 342 |
| APO-IRBESARTAN | 300MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 339 |
| APO-IRBESARTAN | 150MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 336 |
| APO-IMIQUIMOD | 5% | CREAM | Resolved | 2017-03-10 | 2019-11-26 | 333 |
| APO-HYDROCHLOROTHIAZIDE | 100MG | TABLET | Resolved | 2017-03-10 | 2019-11-26 | 330 |
| APO-FUROSEMIDE | 80MG | TABLET | Resolved | 2017-03-10 | 2017-06-05 | 327 |
| APO-FOSINOPRIL | 20MG | TABLET | Resolved | 2017-03-10 | 2017-04-10 | 324 |
| APO-EZETIMIBE | 10MG | TABLET | Resolved | 2017-03-10 | 2017-03-15 | 318 |
| APO-EXEMESTANE | 25MG | TABLET | Resolved | 2017-03-10 | 2019-06-12 | 314 |
| APO-ENTECAVIR | 0.5MG | TABLET | Resolved | 2017-03-10 | 2017-10-11 | 311 |
| APO-ELETRIPTAN | 40MG | TABLET | Resolved | 2017-03-10 | 2020-01-07 | 308 |
| APO-ELETRIPTAN | 20MG | TABLET | Resolved | 2017-03-10 | 2020-01-07 | 305 |
| APO-DORZO-TIMOP | 5MG 20MG | SOLUTION | Resolved | 2017-03-10 | 2019-07-13 | 290 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PRAVASTATIN | 20MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71014 |
| ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
| APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-07-13 | 70805 |
| APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-08-08 | 70807 |
| APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-02-21 | 70802 |
| APO-IBUPROFEN | 400MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70799 |
| APO-IBUPROFEN | 300MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70793 |
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70787 |
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
| APO-CICLESONIDE | 50MCG | SPRAY, METERED DOSE | Discontinued | 2018-12-20 | 2018-12-21 | 70250 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-11-19 | 2018-11-19 | 67146 |
| ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2018-10-25 | 2018-10-25 | 65585 |
| APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Discontinued | 2018-10-11 | 2018-10-11 | 63845 |